Avantor (AVTR)
Health Care · Life sciences distribution and specialty chemical manufacturing for biopharma
Global provider of mission-critical laboratory consumables, specialty chemicals, and biopharmaceutical manufacturing solutions serving life sciences, healthcare, and advanced technology markets worldwide.
What Avantor does
Avantor is a global provider of mission-critical products and services to customers in life sciences, healthcare, biopharma, and advanced technologies. The company operates through two primary business models: VWR, a global distribution channel for laboratory consumables, equipment, and services serving millions of SKUs from thousands of suppliers; and specialty product manufacturing, including high-purity chemicals (J.T. Baker), fluid handling systems (Masterflex), and medical-grade silicone (NuSil). The company serves more than 300,000 customer locations across approximately 180 countries, with over 85% of net sales from recurring product and service offerings.
Themes: ["Biopharma manufacturing and bioprocessing","Laboratory distribution and services","Life sciences consumables and reagents","Medical device materials and silicones","Scientific equipment and instrumentation","Specialty chemicals and excipients","Contract manufacturing and supply chain optimization"]
Fundamentals
- Price$10.51 as of 2026-07-09 close
- Market cap$7.2B as of 2026-07-10
- 1-year return-29.0% as of 2026-07-09 close
- Net margin-8.4% as of 2026-07-10
- Gross margin+32.1% as of 2026-07-10
- ROE-9.6% as of 2026-07-10
- Debt / equity0.68 as of 2026-07-10
- Revenue growth (YoY)-2.0% as of 2026-07-10
- Revenue CAGR (3y)-4.5% SEC XBRL
- Beta0.93 as of 2026-07-10
Dividend: does not currently pay a dividend.
Key risks (from latest filing)
["Dependence on sole or limited sources for essential materials and components, creating supply chain vulnerability","Significant customer concentration and reliance on maintaining relationships with major pharmaceutical manufacturers and contract manufacturing organizations","Exposure to adverse macroeconomic trends affecting consumer, business, and government spending, and impacts from regulatory changes in life sciences and healthcare industries"]
Competitors & peers
- Thermo Fisher Scientific
- Danaher Corporation
- Charles River Laboratories
- Lonza Group
- Cytiva (Danaher subsidiary)
- STEMCELL Technologies
- Sigma-Aldrich (Merck subsidiary)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.